ATX-011

N/A

Report date: 2026/05/09 20:00:18
First In Class

Base Information

Drug NameATX-011
Drug Alias NameATX-011ATX011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsThrombocythemia, Essential
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlethio Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlethio Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsThrombocythemia, Essential
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A